0001520138-26-000499.txt : 20261119 0001520138-26-000499.hdr.sgml : 20261119 20261118175925 ACCESSION NUMBER: 0001520138-26-000499 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261119 DATE AS OF CHANGE: 20261118 EFFECTIVENESS DATE: 20261119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-605260 FILM NUMBER: 261571755 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 D 1 primary_doc.xml X0708 D LIVE 0001580149 BIOVIE INC. 680 W. NYE LANE, SUITE 201 CARSON CITY NV NEVADA 89703 775-888-3162 NEVADA None NANOANTIBIOTICS, INC. Corporation true Cuong Do c/o BioVie Inc. 680 W NYE LANE, SUITE 201 CARSON CITY NV NEVADA 89703 Executive Officer President and CEO Joanne Wendy Kim c/o BioVie Inc. 680 W NYE LANE, SUITE 201 Carson City NV NEVADA 89703 Executive Officer CFO Sigmund Rogich c/o BioVie Inc. 680 W NYE LANE, SUITE 201 Carson City NV NEVADA 89703 Director Michael Sherman c/o BioVie Inc. 680 W NYE LANE, SUITE 201 Carson City NV NEVADA 89703 Director Kameel Farag c/o BioVie Inc. 680 W NYE LANE, SUITE 201 Carson City NV NEVADA 89703 Director Amy Chappell c/o BioVie Inc. 680 W NYE LANE, SUITE 201 Carson City NV NEVADA 89703 Director Jim Lang c/o BioVie Inc. 680 W NYE LANE, SUITE 201 Carson City NV NEVADA 89703 Director Biotechnology Decline to Disclose 06b false 2026-11-03 false true true false 0 0 0 0 The warrants were issued without additional consideration in connection with a registered offering of common stock at $1.60 per share and accompanying warrant. No separate consideration was paid. false 1 0 0 0 false BIOVIE INC. /s/ Joanne Wendy Kim Joanne Wendy Kim CFO 2026-11-18